Agilent Technologies Completes Acquisition of Silicon Genetics


Agilent Technologies Inc. announced the completion of its acquisition of silicon Genetics, a leading provider of software solutions for life science discovery. Agilent and Silicon Genetics had announced an acquisition agreement Aug. 23, 2004. Financial details of the agreement were not disclosed.

Silicon Genetics, based in Redwood City, Calif., has been recognized as one of the fastest-growing technology companies in North America. Its customers include more than 600 leading pharmaceutical companies, academic institutions and major research organizations around the world. With the addition of Silicon Genetics' genomics data analysis and management tools to its portfolio, Agilent will become a market leader in life science informatics.

Together, Silicon Genetics and Agilent will form a life science informatics team that will create products spanning DNA, RNA, protein and pathway applications. The team will sell and support the products developed by Silicon Genetics, the Rosetta Resolver and Luminator gene expression data analysis systems, the Agilent Spectrum Mill proteomics workbench and the Agilent Synapsia informatics workbench. The team will also work closely with customers and partners to develop functionality for new life science research applications.

Most of Silicon Genetics' 50 employees have joined Agilent and are part of the company's Life Sciences and Chemical Analysis business in Santa Clara, Calif.

Other news from the department business & finance

Most read news

More news from our other portals

Under the magnifying glass: The world of microscopy